Experiments for taxon Nocardia species (NOCARDIACEAE)

Experiments (37 results)

Filters
Worktypes (16)
13
8
7
6
5
4
4
2
2
1
1
1
1
1
1
1
No match
Pharmacology (13)
5
4
2
2
1
1
1
1
1
1
1
1
16
No match
Compounds (17)
12
11
11
3
2
1
1
1
1
1
1
1
1
1
1
1
1
No match
Organisms (11)
12
10
4
2
2
2
1
1
1
1
1
No match
37 experiments
No experiment matches the selected filters.
ExperimentWorktypesPharmacologyOrganism (specimen)Compound
82047
PHARMACOLOGY OF COMPOUND - IN VITRO
RNA POLYMERASE INHIBITION
Nocardia species (NOCARDIACEAE)
SAKYOMICIN A
82049
PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
VIRUS FOCUS FORMATION INHIBITION
Nocardia species (NOCARDIACEAE)
SAKYOMICIN A
981904
PHARMACOLOGY OF COMPOUND - IN VITRO
MICROTUBULE DEPOLYMERIZATION
Nocardia species (NOCARDIACEAE)
MAYTANSINOL ISO-VALERATEMAYTANSINOL ISO-BUTYRATE
333421
MICROBIAL TRANSFORMATION OF
Nocardia species (NOCARDIACEAE)
CHOLESTEROL
981899
PHARMACOLOGY OF COMPOUND - IN VIVOANTICANCER AND/OR CYTOTOXICITY MARKER CODE
ANTILEUKOPENIC ACTIVITY
Nocardia species (NOCARDIACEAE)
MAYTANSINOL ISO-VALERATEMAYTANSINOL ISO-BUTYRATE
887579
MICROBIAL TRANSFORMATION OF
Nocardia species (NOCARDIACEAE)
PREGNAN-20-ONE-3-BETA-21-DIACETATE,17-ALPHA-HYDROXY:
1007496
PRESENT IN (REVIEW)
Nocardia species (NOCARDIACEAE)
MAYTANSINOL ISO-VALERATEMAYTANSINOL ISO-BUTYRATE
1001584
MICROBIAL TRANSFORMATION OF
Nocardia species (NOCARDIACEAE)
ANDROSTANE-3-BETA-17-BETA-DIOL,5-ALPHA: 17-ALPHA-METHYL:
82042
PHARMACOLOGY OF COMPOUND - IN VITRO
CYTOTOXIC ACTIVITY
Nocardia species (NOCARDIACEAE)
SAKYOMICIN A
1039531
UV SPECTRUM GIVEN FORCD SPECTRUM REPORTED FORISOLATION AND IDENTIFICATION OF
Nocardia species (NOCARDIACEAE)
NOCARDIA ANTIBIOTIC LL-BM-782-ALPHA-2NOCARDIA ANTIBIOTIC LL-BM-123-ALPHA
82041
ISOLATION AND IDENTIFICATION OF
Nocardia species (NOCARDIACEAE)
SAKYOMICIN A
887581
ISOLATION FOLLOWING BIOLOGICAL CONVERSION BY
Nocardia species (NOCARDIACEAE)
REICHSTEIN S,1-DEHYDRO:REICHSTEIN S
619575
PMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDISOLATION OF A COMPOUND WITH NOVEL STRUCTUREANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
Nocardia species (NOCARDIACEAE)
NOCARDIA ANTIBIOTIC LL-BM-123-ALPHA
1001583
MICROBIAL TRANSFORMATION OF
Nocardia species (NOCARDIACEAE)
ANDROSTANE-3-BETA-17-BETA-DIOL,5-ALPHA: 17-ALPHA-METHYL:
981903
PHARMACOLOGY OF COMPOUND - IN VIVOANTICANCER AND/OR CYTOTOXICITY MARKER CODE
ANTITUMOR ACTIVITY
Nocardia species (NOCARDIACEAE)
MAYTANSINOL ISO-VALERATEMAYTANSINOL ISO-BUTYRATE
981900
PHARMACOLOGY OF COMPOUND - IN VIVOANTICANCER AND/OR CYTOTOXICITY MARKER CODE
ANTITUMOR ACTIVITY
Nocardia species (NOCARDIACEAE)
MAYTANSINOL ISO-VALERATEMAYTANSINOL ISO-BUTYRATE
1001582
MICROBIAL TRANSFORMATION OF
Nocardia species (NOCARDIACEAE)
ANDROSTANE-3-BETA-17-BETA-DIOL,5-ALPHA: 17-ALPHA-METHYL:
981905
PHARMACOLOGY OF COMPOUND - IN VITRO
TUBULIN POLYMERIZATION INHIBITION
Nocardia species (NOCARDIACEAE)
MAYTANSINOL ISO-VALERATEMAYTANSINOL ISO-BUTYRATE
82052
PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
VIRUS FOCUS FORMATION INHIBITION
Nocardia species (NOCARDIACEAE)
SAKYOMICIN A
82043
PHARMACOLOGY OF COMPOUND - IN VIVOTOXICITY MARKER CODE
TOXICITY ASSESSMENT(QUANTITATIVE)
Nocardia species (NOCARDIACEAE)
SAKYOMICIN A
82044
PHARMACOLOGY OF COMPOUND - IN VITRO
REVERSE TRANSCRIPTASE INHIBITION
Nocardia species (NOCARDIACEAE)
SAKYOMICIN A
1028441
ISOLATION FOLLOWING BIOLOGICAL CONVERSION BY
Nocardia species (NOCARDIACEAE)
SPIROLACTONE
981901
PHARMACOLOGY OF COMPOUND - IN VIVOANTICANCER AND/OR CYTOTOXICITY MARKER CODE
ANTITUMOR ACTIVITY
Nocardia species (NOCARDIACEAE)
MAYTANSINOL ISO-VALERATEMAYTANSINOL ISO-BUTYRATE
981897
PHARMACOLOGY OF COMPOUND - IN VIVOANTICANCER AND/OR CYTOTOXICITY MARKER CODEISOLATION AND IDENTIFICATION OF
ANTITUMOR ACTIVITY
Nocardia species (NOCARDIACEAE)
MAYTANSINOL ISO-VALERATEMAYTANSINOL ISO-BUTYRATE
981906
PHARMACOLOGY OF COMPOUND - IN VITRO
TUBULIN AGGREGATION EFFECT
Nocardia species (NOCARDIACEAE)
MAYTANSINOL ISO-VALERATEMAYTANSINOL ISO-BUTYRATE
82051
PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
VIRUS FOCUS FORMATION INHIBITION
Nocardia species (NOCARDIACEAE)
SAKYOMICIN A
998005
ISOLATION OF A COMPOUND WITH NOVEL STRUCTUREPATENT DESCRIBED
Nocardia species (NOCARDIACEAE)
NOCARDIA ANTIBIOTIC BM-123-GAMMA-2NOCARDIA ANTIBIOTIC BM-123-GAMMA-1
981902
PHARMACOLOGY OF COMPOUND - IN VIVOANTICANCER AND/OR CYTOTOXICITY MARKER CODE
ANTITUMOR ACTIVITY
Nocardia species (NOCARDIACEAE)
MAYTANSINOL ISO-VALERATEMAYTANSINOL ISO-BUTYRATE
82050
PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
VIRUS FOCUS FORMATION INHIBITION
Nocardia species (NOCARDIACEAE)
SAKYOMICIN A
82045
PHARMACOLOGY OF COMPOUND - IN VITRO
DNA POLYMERASE INHIBITION
Nocardia species (NOCARDIACEAE)
SAKYOMICIN A
1001585
ISOLATION FOLLOWING BIOLOGICAL CONVERSION BY
Nocardia species (NOCARDIACEAE)
TESTOSTERONE,DEHYDRO: 17-ALPHA-METHYL:
333422
ISOLATION FOLLOWING BIOLOGICAL CONVERSION BY
Nocardia species (NOCARDIACEAE)
CHOLEST-4-ENE-3-ONE
82048
PHARMACOLOGY OF COMPOUND - IN VITRO
VIRUS INDUCTION INHIBITION
Nocardia species (NOCARDIACEAE)
SAKYOMICIN A
82046
PHARMACOLOGY OF COMPOUND - IN VITRO
DNA POLYMERASE INHIBITION
Nocardia species (NOCARDIACEAE)
SAKYOMICIN A
981898
PHARMACOLOGY OF COMPOUND - IN VIVOANTICANCER AND/OR CYTOTOXICITY MARKER CODE
ANTILEUKOPENIC ACTIVITY
Nocardia species (NOCARDIACEAE)
MAYTANSINOL ISO-VALERATEMAYTANSINOL ISO-BUTYRATE
1002094
QUANTITATIVE DATAPATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Nocardia species (NOCARDIACEAE)
RIFAMYCIN B
1028440
MICROBIAL TRANSFORMATION OF
Nocardia species (NOCARDIACEAE)
PROPIOLACTONE,3'-(5-ALPHA-3-BETA-17-BETA-DIHYDROXY-ANDROSTANE-17-ALPHA):